Filter
2252
Filtered Results: 2252
Text search:
drug
interactions
Featured
Recommendations
221
New Publications
540
Language
Document type
No document type
1434
Studies & Reports
290
Guidelines
285
Manuals
103
Strategic & Response Plan
55
Training Material
41
Fact sheets
32
Situation Updates
8
Resource Platforms
2
Infographics
2
Countries / Regions
India
129
Global
75
Kenya
72
South Africa
62
Ethiopia
49
Western and Central Europe
48
Nigeria
45
Nepal
43
Uganda
41
Tanzania
40
Sierra Leone
35
Malawi
35
Latin America and the Carribbean
33
Liberia
31
Zambia
29
Ghana
27
Bangladesh
27
Africa
25
Ukraine
23
Myanmar / Burma
22
Rwanda
21
Namibia
21
Eastern Europe
19
Cambodia
16
Russia
16
Lesotho
15
Philippines
15
Botswana
15
South–East Asia Region
14
Zimbabwe
12
Asia
11
Congo, Democratic Republic of
11
Eswatini/ Swaziland
9
Syria
8
Mozambique
8
USA
8
Eastern Europe and Central Asia
7
Indonesia
7
Germany
6
West and Central Africa
6
Middle East and North Africa
6
Tajikistan
5
Brazil
5
South Sudan
5
Thailand
4
Afghanistan
4
Haiti
4
North America
4
East and Southern Africa
4
Georgia
4
Pakistan
4
Chile
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Guinea
3
Western Pacific Region
3
United Kingdom
3
Vietnam
3
North Macedonia
2
Colombia
2
Kazakhstan
2
Kyrgyzstan
2
Peru
2
Armenia
2
Argentina
2
Sri Lanka
2
Sudan
2
Yemen
2
Iraq
2
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Gambia
1
China
1
Iran
1
Canada
1
Senegal
1
Estonia
1
Austria
1
Qatar
1
Venezuela
1
Ireland
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Spain
1
Belarus
1
Southern Africa
1
Bolivia
1
Papua New Guinea
1
Palestine
1
Libya
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
770
Clinical Guidelines
237
Public Health
138
Women & Child Health
70
Key Resources
53
Capacity Building
47
Pharmacy & Technologies
11
Toolboxes
Mental Health
327
HIV
260
TB
230
COVID-19
97
AMR
88
NTDs
78
Pharmacy
62
NCDs
50
Caregiver
44
Disability
39
Planetary Health
37
Ebola & Marburg
32
Global Health Education
30
Rapid Response
28
Refugee
20
Conflict
13
Polio
10
Specific Hazards
8
Social Ethics
8
Health Financing Toolbox
8
Malaria
7
Cholera
6
Natural Hazards
5
Zika
2
Perspectives on Drugs
EMCDDA Insights - 11
Accessed: 14.03.2019
Accessed December 2017
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Guidance Brief
Selected findings from ECDC and EMCDDA scientific guidance, 2018
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
World Drug Report 2018
-4-
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
International Journal of Drug Policy 24 (2013) e91-98
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
